Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value ($000): $343,460 (100.0% shares, 0.0% debt)

Holdings (17)

— Medivation, Inc. 82.6%

Value ($000) $283,814 Shares 2,198,919 Est. Cost $49.20 Unrealized —

— Ampio Pharmaceuticals Inc. 7.4%

Value ($000) $25,514 Shares 3,388,322 Est. Cost $6.03 Unrealized —

— Synthetic Biologics Inc. 2.2%

Value ($000) $7,448 Shares 3,400,816 Est. Cost $1.48 Unrealized —

— Alcobra Ltd 1.8%

Value ($000) $6,279 Shares 1,115,315 Est. Cost $7.08 Unrealized —

— Newlink Genetics Corp 1.6%

Value ($000) $5,604 Shares 102,437 Est. Cost $27.98 Unrealized —

— Advaxis Inc. 1.2%

Value ($000) $3,971 Shares 275,000 Est. Cost $14.44 Unrealized —

— Keryx Biopharmaceuticals Inc. 0.7%

Value ($000) $2,546 Shares 200,000 Est. Cost $10.21 Unrealized —

— Bio Blast Pharma Ltd 0.6%

Value ($000) $2,029 Shares 338,110 Est. Cost $7.27 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.4%

Value ($000) $1,382 Shares 135,800 Est. Cost $10.20 Unrealized 0.0%

— Lion Biotechnologies Inc 0.4%

Value ($000) $1,211 Shares 100,000 Est. Cost $12.11 Unrealized —

— Advaxis Inc. 0.3%

Value ($000) $1,170 Shares 112,500 Est. Cost $10.40 Unrealized —

— PlasmaTech Biopharmaceutical 0.2%

Value ($000) $669 Shares 213,100 Est. Cost $3.14 Unrealized —

— Galmed Pharmaceuticals Ltd 0.2%

Value ($000) $612 Shares 65,000 Est. Cost $11.48 Unrealized —

— OHR Pharmaceutical Inc 0.2%

Value ($000) $521 Shares 205,000 Est. Cost $2.54 Unrealized —

— Evoke Pharma Inc 0.1%

Value ($000) $380 Shares 53,839 Est. Cost $7.06 Unrealized —

— Zosano Pharma Corp 0.1%

Value ($000) $202 Shares 20,000 Est. Cost $10.10 Unrealized —

— Aptose Biosciences Inc 0.0%

Value ($000) $108 Shares 20,000 Est. Cost $5.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,198,919	$283,814	82.6%	$49.20	—	COM	58501N101
—	Ampio Pharmaceuticals Inc.	3,388,322	$25,514	7.4%	$6.03	—	COM	03209T109
—	Synthetic Biologics Inc.	3,400,816	$7,448	2.2%	$1.48	—	COM	87164U102
—	Alcobra Ltd	1,115,315	$6,279	1.8%	$7.08	—	SHS	M2239P109
—	Newlink Genetics Corp	102,437	$5,604	1.6%	$27.98	—	COM	651511107
—	Advaxis Inc.	275,000	$3,971	1.2%	$14.44	—	COM NEW	007624208
—	Keryx Biopharmaceuticals Inc.	200,000	$2,546	0.7%	$10.21	—	COM	492515101
—	Bio Blast Pharma Ltd	338,110	$2,029	0.6%	$7.27	—	SHS	M20156101
ALDX	Aldeyra Therapeutics Inc	135,800	$1,382	0.4%	$10.20	0.0%	COM	01438T106
—	Lion Biotechnologies Inc	100,000	$1,211	0.4%	$12.11	—	COM	53619R102
—	Advaxis Inc.	112,500	$1,170	0.3%	$10.40	—	W EXP 07/15/201	007624117
—	PlasmaTech Biopharmaceutical	213,100	$669	0.2%	$3.14	—	COM	72754H109
—	Galmed Pharmaceuticals Ltd	65,000	$612	0.2%	$11.48	—	SHS	M47238106
—	OHR Pharmaceutical Inc	205,000	$521	0.2%	$2.54	—	COM NEW	67778H200
—	Evoke Pharma Inc	53,839	$380	0.1%	$7.06	—	COM	30049G104
—	Zosano Pharma Corp	20,000	$202	0.1%	$10.10	—	COM	98979H103
—	Aptose Biosciences Inc	20,000	$108	0.0%	$5.40	—	COM NEW	03835T200